{"title":"Tackling aging and chronic disease: How space exploration and the 'chameleon effect' of pharmaceuticals can lead the way.","authors":"Carina Kern, Tina Woods, Keith Siew","doi":"10.1113/EP092652","DOIUrl":null,"url":null,"abstract":"<p><p>A common misconception surrounding space exploration is that humanity's pursuit of interplanetary travel, such as missions to Mars, is an escape from Earth. In reality, this endeavour offers an invaluable opportunity to address critical biomedical challenges here at home. The extreme conditions of space, including microgravity, cosmic radiation and prolonged isolation, create a natural laboratory for studying human biology under stress, allowing us to explore the boundaries of human resilience. These exposures yield key insights into the biology of aging, the accelerated decline of physiological function and the early onset of chronic diseases. Among the organs most susceptible to environmental stress is the kidney, which is at high risk of failure during long-duration spaceflight. Its sensitivity makes it an ideal model for understanding how stress accelerates degeneration, both in space and on Earth. By studying kidney function alongside broader cellular processes, we can illuminate how stress drives aging and chronic disease. This is particularly exemplified by the process of cellular necrosis (unprogrammed cell death), which represents a key central node as recently demonstrated. Necrosis acts upstream of processes like cellular senescence and tissue degeneration, and is the mechanism through which multiple environmental factors erode resilience and drive the progression of chronic diseases like kidney disease. Following this exploration of how stress accelerates biological decline, we examine strategies that may protect against such damage, preventing disease and preserving physiological resilience. Pharmaceuticals, with their ability to modulate physiology transiently, are especially powerful in dynamic, real-world environments where stressors continually change. This 'chameleon effect' of pharmaceuticals offers the potential to uncouple biological trade-offs and enhance adaptive capacity to stress. Understanding these processes in the space environment provides an unprecedented opportunity, difficult to reproduce on Earth, to identify links between exposure and develop targeted interventions to enhance health and resilience on Earth.</p>","PeriodicalId":12092,"journal":{"name":"Experimental Physiology","volume":" ","pages":"4064-4072"},"PeriodicalIF":3.0000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13487027/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental Physiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1113/EP092652","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/18 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PHYSIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
A common misconception surrounding space exploration is that humanity's pursuit of interplanetary travel, such as missions to Mars, is an escape from Earth. In reality, this endeavour offers an invaluable opportunity to address critical biomedical challenges here at home. The extreme conditions of space, including microgravity, cosmic radiation and prolonged isolation, create a natural laboratory for studying human biology under stress, allowing us to explore the boundaries of human resilience. These exposures yield key insights into the biology of aging, the accelerated decline of physiological function and the early onset of chronic diseases. Among the organs most susceptible to environmental stress is the kidney, which is at high risk of failure during long-duration spaceflight. Its sensitivity makes it an ideal model for understanding how stress accelerates degeneration, both in space and on Earth. By studying kidney function alongside broader cellular processes, we can illuminate how stress drives aging and chronic disease. This is particularly exemplified by the process of cellular necrosis (unprogrammed cell death), which represents a key central node as recently demonstrated. Necrosis acts upstream of processes like cellular senescence and tissue degeneration, and is the mechanism through which multiple environmental factors erode resilience and drive the progression of chronic diseases like kidney disease. Following this exploration of how stress accelerates biological decline, we examine strategies that may protect against such damage, preventing disease and preserving physiological resilience. Pharmaceuticals, with their ability to modulate physiology transiently, are especially powerful in dynamic, real-world environments where stressors continually change. This 'chameleon effect' of pharmaceuticals offers the potential to uncouple biological trade-offs and enhance adaptive capacity to stress. Understanding these processes in the space environment provides an unprecedented opportunity, difficult to reproduce on Earth, to identify links between exposure and develop targeted interventions to enhance health and resilience on Earth.
期刊介绍:
Experimental Physiology publishes research papers that report novel insights into homeostatic and adaptive responses in health, as well as those that further our understanding of pathophysiological mechanisms in disease. We encourage papers that embrace the journal’s orientation of translation and integration, including studies of the adaptive responses to exercise, acute and chronic environmental stressors, growth and aging, and diseases where integrative homeostatic mechanisms play a key role in the response to and evolution of the disease process. Examples of such diseases include hypertension, heart failure, hypoxic lung disease, endocrine and neurological disorders. We are also keen to publish research that has a translational aspect or clinical application. Comparative physiology work that can be applied to aid the understanding human physiology is also encouraged.
Manuscripts that report the use of bioinformatic, genomic, molecular, proteomic and cellular techniques to provide novel insights into integrative physiological and pathophysiological mechanisms are welcomed.